Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Wright (Leicester, United Kingdom), S. Diver (Leicester, United Kingdom), J. Mccarthy (Leicester, United Kingdom), A. Marvin (Leicester, United Kingdom), M. Soares (Leicester, United Kingdom), T. Thornton (Leicester, United Kingdom), M. Bourne (Leicester, United Kingdom), M. Craner (Leicester, United Kingdom), H. Evans (Leicester, United Kingdom), S. Edwards (Leicester, United Kingdom), S. Glover (Leicester, United Kingdom), L. Carr (Leicester, United Kingdom), S. Parker (Leicester, United Kingdom), S. Siddiqui (Leicester, United Kingdom), D. Cousins (Leicester, United Kingdom), C. Brightling (Leicester, United Kingdom). Mepolizumab does not alter blood basophil count in severe asthma. 4396

Member's Comments

No comment yet.

Related content which might interest you: FENO and blood eosinophil count as surrogate barkers of eosinophilic airway inflammation in patients with severe asthma Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 The usefulness of blood eosinophil count and FeNO to predict sputum eosinophilia in the diagnosis of severe eosinophilic asthma Source: International Congress 2019 – Eosinophils and FeNO in airway diseases Year: 2019 The blood eosinophil count as a biomarker in COPD Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD Year: 2015 Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study Source: Eur Respir J, 51 (5) 1702523; 10.1183/13993003.02523-2017 Year: 2018 Accuracy of blood eosinophil count in predicting sputum eosinophils in children with problematic severe asthma (PSA) Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma Year: 2020 Blood eosinophil count and exacerbation risk in patients with COPD Source: Eur Respir J, 50 (1) 1700761; 10.1183/13993003.00761-2017 Year: 2017 Blood eosinophil count to predict bronchial eosinophilic inflammation in COPD Source: Eur Respir J 2016; 47:1562-1564 Year: 2016 Theophylline drip infusion reduces peripheral blood eosinophil counts and ECP (eosinophil cationic protein) level on acute exacerbation of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 108s Year: 2002 Reproducibility of COPD blood eosinophil counts Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 Treatment of moderate-severe asthma with omalizumab is associated with a decrease in peripheral blood eosinophils Source: Eur Respir J 2007; 30: Suppl. 51, 353s Year: 2007 Peripheral blood eosinophil counts and serum total IgE on broncholdilator responsiveness in patients with stable COPD Source: Eur Respir J 2003; 22: Suppl. 45, 279s Year: 2003 The reproducibility of COPD blood eosinophil counts Source: Eur Respir J, 52 (1) 1800427; 10.1183/13993003.00427-2018 Year: 2018 Blood eosinophil count as a predictor of treatment response in adult patients with chronic cough Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights Year: 2020 Association between blood eosinophil count and control of allergic rhinitis: does it exist? Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses Year: 2019 Systemic inflammation, blood eosinophils count and lung function in COPD patients Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017 Biological markers of inflammation in asthma in children - eosinophils in sputum and ECP in peripheral blood Source: Eur Respir J 2005; 26: Suppl. 49, 625s Year: 2005 Blood eosinophil (EOS) count, exacerbation rate and response to roflumilast in patients with severe COPD Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017 Lack of seasonal variability of blood eosinophil counts in COPD Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Association between blood eosinophil count and risk of exacerbations in patients with COPD Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 Role of blood neutrophilia as a biomarker in asthma Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018